线粒体结构异常和心脏逆转重塑在患有缩功能障碍的患者
Koji Nakano1, Masayoshi Yamamoto1, Yu Yamada1
1Department of Cardiology, Institute of Medicine, University of Tsukuba.
概括
在心力衰竭患者中,线粒体晶体的失调与更糟糕的结果和逆向重塑有关. 这一发现可能会影响心力衰竭管理策略.
科学领域:
- 心脏病学 心脏病学
- 线粒体生物学 线粒体生物学
- 病理学 病理学 病理学
背景情况:
- 线粒体功能障碍与心力衰竭 (HF) 有关.
- 在HF患者中,结构性线粒体异常的临床影响尚不清楚.
研究的目的:
- 为了研究线粒体结构异常与左心室 (LV) 缩功能障碍患者的临床结果之间的关联.
主要方法:
- 电子显微镜用于分析91名患有LV静脉缩功能障碍的患者的心肌样本中的线粒体结构 (大小,外膜,晶状体).
- 患者根据LV反向改造 (LVRR) 状态进行了分类.
- 临床结果,包括心血管死亡和HF住院治疗,在活检后的一年内被跟踪.
主要成果:
- 在23.1%的患者中发现了晶状体失调,并且在LVRR阴性组 (38.5%) 与LVRR阳性组 (11.5%) 相比,在LVRR阴性组 (38.5%) 中明显更常见.
- 晶状体失调独立地与心血管死亡和HF住院治疗的复合终点相关 (P=0.002).
- 即使调整了诸如年龄,血压,B型性尿素和性排泄等因素后,这种关联仍然显著.
结论:
- 线粒体晶状体失调是一种结构异常,与LV逆向重塑和静脉缩功能障碍患者的预后较差有关.
- 这些发现表明,线粒体结构评估,特别是状体的完整性,可以在管理高风患者中具有价值.
相关概念视频
Cardiomyopathy III: Hypertrophic Cardiomyopathy
1
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
1
Heart Failure II: Pathophysiology
3
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
3
Cardiomyopathy II: Dilated Cardiomyopathy
1
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
1
Cardiomyopathy IV: Restrictive Cardiomyopathy
2
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
2
Cardiomyopathy I: Introduction and Classification
2
Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
2
Pathophysiology of Heart Failure
1.5K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.5K


